The Influence of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation

The Influence of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation, A Single Centre Prospective Cohort Study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200059079

Enrollment

Unknown

Registered

2022-04-24

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

Control group:None

NAFLD Group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age > 18 years old; 2. Symptomatic paroxysmal or persistent atrial fibrillation; 3. Radiofrequency ablation or cryoballoon ablation was performed.

Exclusion criteria

Exclusion criteria: 1. A previous diagnosis of NAFLD; 2. Active malignancy; 3. Connective tissue disease; 4. Severe renal/hepatic dysfunction; 5. Rheumatic heart disease; 6. Congenital heart disease; 7. A prior diagnosis with acute myocardial infarction, a prior history of a cardiac procedure.

Design outcomes

Primary

Measure	Time frame
Arrhythmia recurrence;	—

Secondary

Measure	Time frame
The Atrial Fibrillation Effect on QualiTy of Life;European Heart Rhythm Association (EHRA) score;	—

Countries

China

Contacts

Public ContactYunling Lin

Fujian Medical University Union Hospital

fmulyl@163.com+86 15080025322

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 15, 2026